Montelukast+Levocetirizine a combined therapy is prescribed for the systemic treatment of allergic reactions such as chronic urticaria, obstructive airway diseases and rhinitis. Montelukast belongs to leucotriene receptor antagonist.
No information available
No information available
No information available
Montelukast + Levocetirizine can cause somnolence, hyperactivity in children, dry mouth, mild drowsiness and GI disturbances.
Montelukast + Levocetirizine is contraindicated in patients with an allergy to either or both drugs, hepatic impairment, NSAID allergy, Churg-Strauss syndrome.
Montelukast + Levocetirizine is contraindicated in children less than six months of age.
Montelukast + Levocetirizine can cause dizziness. Do not drive vehicles or operate heavy machineries that need alertness.
No information available
Montelukast + Levocetirizine may interact with phenytoin, CNS depressants, rifampicin, prednisone and phenobarbital.
Do not consume alcohol while taking Montelukast + Levocetirizine
For treatment of allergic rhinitis and chronic asthma (Adults):
Consider administration of 10 mg once a day in the evening.
For Prophylaxis of exercise-induced asthma (Adults):
Consider administration of 10 mg of Montelukast + Levocetirizine, at least two hours before exercise.
No information available
USFDA pregnancy category B. Montelukast + Levocetirizine may not cause harm to an unborn foetus. Before Montelukast treatment, the patient should discuss with the physician, if they are planning for a pregnancy.
It is unclear whether the drug could pass through the breast milk to a breast feeding baby. Consult your physician before taking Montelukast + Levocetirizine, if you are nursing mother.
No information available
No information available
No information available
No information available
No information available
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.